MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-18-0019858
Market Cap
₹110 Cr
MAKERSL · NSE
Share Price
₹192.00
+3.38% today
Revenue
₹141 Cr
FY 2025-26 · +16.4% YoY
EBITDA
₹14.82 Cr
Margin 10.5%
Net Profit
₹2.09 Cr
FY 2025-26 · +157.0% YoY
P/E (TTM)
32.3x
P/B 1.5x
ROE
11.0%
ROCE 14.9%
Debt / Equity
0.12
Interest cover 8.3x
About Makers Laboratories Ltd
Data last updated:
Makers Laboratories Ltd is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 July 1984 and has been in existence for over 42 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L24230MH1984PLC033389. Its GSTIN is 27AAACM8382J2Z1 (Maharashtra). The company holds 14 GST registrations, of which 4 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 506919 and NSE: MAKERSL.
The company has an authorised share capital of ₹7.5 Cr and a paid-up capital of ₹5.9 Cr. It is led by directors including Saahil Umesh Parikh (Whole-Time Director) and Nilesh Jain (Whole-Time Director).
Its last annual general meeting (AGM) was held on 08 August 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Plot No. 54D Kandivli Industrial Estate Kandivli(West), Mumbai, Maharashtra, India – 400067.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹140.59 Cr, a growth of 16.4% compared to the previous year. For the same year it recorded a net profit of ₹2.09 Cr (net margin 1.5%) and EBITDA of ₹14.82 Cr (EBITDA margin 10.5%). The net worth stands at ₹72.92 Cr (up 3.4% YoY). Total assets are valued at ₹131.63 Cr (up 6.8% YoY).
The company has about 139 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Makers Laboratories. As per MCA filings, the company has open charges of ₹21.32 Cr and satisfied charges of ₹30.67 Cr on record. Court records list 51 cases involving the company, including 42 filed by the company and 9 filed against it; 18 cases are pending. The company has 33 deals on record (32 market trades, 1 rights issue); the latest was in May 2026. Its 9 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 4 smaller; the largest is Surabhi Industries (India) Private Limited with revenue of ₹133.75 Cr. The company has 15 MSME Form 1 returns on record between 2019 and 2024, listing 512 overdue payments to 70 micro and small suppliers.
Makers Laboratories Ltd is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0019858). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website makerslabs.com.
Company details
CIN L24230MH1984PLC033389
Registration Number 033389
Incorporation Date 09 July 1984
ROC Mumbai
Listing Status Listed - Listed on NSE (MAKERSL); Listed on BSE (506919)
Company Status Active
Date of Last AGM 08 August 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-18-0019858
CIN history
Makers Laboratories has one previous CIN (Corporate Identification Number): U24230MH2004PTC033389. The current CIN is L24230MH1984PLC033389, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24230MH1984PLC033389 | Current |
| U24230MH2004PTC033389 | Previous |
Key People
Saahil Umesh Parikh Whole-Time Director Nilesh Jain Whole-Time Director Raj Kamal Prasad Verma Director Recognitions & Rankings of Makers Laboratories
Contact details
Makers Laboratories Ltd's registered office is in Mumbai, Maharashtra. Its website is makerslabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. 54D Kandivli Industrial Estate Kandivli(West), Mumbai, Maharashtra, India – 400067
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Makers Laboratories Ltd, buy the company report.
Comprehensive company report
Makers Laboratories Ltd - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Makers Laboratories operates one associated brand: Makers Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Branded generic pharmaceutical products are manufactured across multiple therapeutic segments. | makerslabs.com |
Business activity
The main business activity of Makers Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Makers Laboratories Ltd, buy the company report.
Financials of Makers Laboratories Ltd
FY 2025-26 filings availableMakers Laboratories Ltd reported revenue of ₹140.59 Cr (up 16.4% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue
₹141 Cr
+16.4% YoY
EBITDA
₹14.82 Cr
+95.0% YoY
Profit After Tax
₹2.09 Cr
+156.9% YoY
Net Worth
₹72.92 Cr
+3.4% YoY
Total Assets
₹132 Cr
+6.8% YoY
Total Debt
₹8.74 Cr
+12.3% YoY
Revenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | 141 | 121 | 104 | 101 | 127 | 68.64 |
| Revenue growth | +16.4% | +15.7% | +3.1% | -20.4% | +85.3% | - |
| EBITDA | 14.82 | 7.60 | 1.12 | 3.33 | 18.82 | 8.12 |
| EBITDA margin | +10.5% | +6.3% | +1.1% | +3.3% | +14.8% | +11.8% |
| Profit before tax | 11.15 | 13.41 | (3.91) | (0.83) | 15.70 | 2.71 |
| Net profit | 2.09 | (3.67) | (6.29) | (4.76) | 4.97 | (0.42) |
| Net profit margin | +1.5% | -3.0% | -6.0% | -4.7% | +3.9% | -0.6% |
| EPS (₹) | 3.98 | 12.70 | (10.62) | (8.05) | 10.12 | (0.67) |
| Balance sheet | ||||||
| Total assets | 132 | 123 | 128 | 128 | 122 | 107 |
| Net worth | 72.92 | 70.51 | 63.05 | 69.20 | 59.58 | 54.13 |
| Total debt | 8.74 | 7.78 | 22.13 | 16.71 | 23.00 | 20.51 |
| Cash & bank | 0.63 | 0.65 | 2.23 | 4.37 | 8.67 | 6.22 |
| Net working capital | 48.05 | 51.44 | 41.26 | 46.31 | 48.27 | 39.95 |
| Cash flow | ||||||
| Cash from operations | 14.29 | (4.08) | 0.84 | (8.62) | 18.50 | 0.00 |
| Cash from investing | (14.69) | 19.75 | (6.89) | 1.25 | (21.79) | 0.00 |
| Cash from financing | 0.35 | (15.84) | 5.74 | 5.78 | 0.33 | 0.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 42.77 | 35.75 | 35.67 | 34.17 | 35.00 | 33.90 | 27.69 | 29.57 |
| Revenue growth (YoY) | +22.2% | +5.5% | +28.8% | +15.6% | +18.3% | - | - | - |
| Other income | 0.61 | 0.76 | 0.33 | 0.36 | 0.27 | 0.12 | 0.87 | 10.63 |
| EBITDA | 6.96 | 5.27 | 4.17 | 2.28 | 3.01 | 3.06 | 1.31 | 2.19 |
| EBITDA margin | +16.3% | +14.7% | +11.7% | +6.7% | +8.6% | +9.0% | +4.7% | +7.4% |
| Depreciation | 1.13 | 1.13 | 1.14 | 1.13 | 1.12 | 0.90 | 1.31 | 1.29 |
| Interest | 0.15 | 0.17 | 0.20 | 0.22 | 0.18 | 0.18 | 0.19 | 0.43 |
| Profit before tax | 6.29 | 4.73 | 3.16 | 1.29 | 1.98 | 2.10 | 0.68 | 11.10 |
| Tax | 1.70 | 1.18 | 0.88 | 0.55 | 0.69 | 0.52 | 0.41 | 1.33 |
| Net profit | 4.59 | 3.55 | 2.28 | 0.74 | 1.29 | 1.58 | 0.27 | 9.77 |
| EPS (₹) | 2.55 | 1.85 | 1.59 | (0.20) | 0.74 | (0.08) | (0.50) | 14.94 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 50.35 | 42.94 | 49.09 | 42.55 | 52.38 | 44.41 | 51.31 |
| Revenue growth | +17.3% | -12.5% | +15.4% | -18.8% | +18.0% | -13.5% | - |
| EBITDA | 0.73 | (2.21) | (3.76) | (4.12) | 3.07 | 3.31 | 2.73 |
| EBITDA margin | +1.5% | -5.2% | -7.7% | -9.7% | +5.9% | +7.5% | +5.3% |
| Profit before tax | (2.01) | 4.92 | (6.95) | (6.76) | 0.33 | (2.08) | 0.27 |
| Net profit | (1.73) | (5.76) | (6.97) | (6.36) | 0.23 | (1.79) | (0.10) |
| Net profit margin | -3.4% | -13.4% | -14.2% | -15.0% | +0.4% | -4.0% | -0.2% |
| EPS (₹) | (2.91) | 7.87 | (11.78) | (10.78) | 0.35 | (3.29) | (0.25) |
| Balance sheet | |||||||
| Total assets | 58.58 | 58.00 | 67.99 | 70.69 | 69.90 | 65.83 | 57.85 |
| Net worth | 54.43 | 56.08 | 51.45 | 58.28 | 50.30 | 49.62 | 44.62 |
| Total debt | 3.88 | 1.76 | 15.37 | 11.20 | 19.40 | 15.99 | 13.05 |
| Cash & bank | 0.03 | 0.04 | 0.07 | 0.08 | 0.14 | 0.34 | 0.96 |
| Net working capital | 5.29 | 3.16 | 2.89 | 5.26 | 6.40 | 10.39 | 9.42 |
| Cash flow | |||||||
| Cash from operations | (2.02) | (1.59) | (3.06) | (1.42) | 6.80 | 0.67 | 4.23 |
| Cash from investing | 0.28 | 16.14 | (2.04) | (3.55) | (8.78) | (2.65) | (8.43) |
| Cash from financing | 1.75 | (14.56) | 5.12 | 4.94 | 1.77 | 1.37 | 2.91 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 10.19 | 11.27 | 12.70 | 12.64 | 13.73 | 9.70 | 9.45 | 11.50 |
| Revenue growth (YoY) | -25.8% | +16.2% | +34.4% | +9.9% | +11.7% | - | - | - |
| Other income | 0.07 | 0.02 | 0.00 | 0.53 | 0.04 | 0.03 | 0.57 | 10.19 |
| Total expenses | 10.69 | 11.65 | 11.99 | 12.72 | 13.26 | 10.91 | 10.01 | 11.67 |
| EBITDA | (0.50) | (0.38) | 0.71 | (0.08) | 0.47 | (1.21) | (0.56) | (0.17) |
| EBITDA margin | -4.9% | -3.4% | +5.6% | -0.6% | +3.4% | -12.5% | -5.9% | -1.5% |
| Depreciation | 0.69 | 0.69 | 0.71 | 0.71 | 0.70 | 0.69 | 0.73 | 0.71 |
| Interest | 0.14 | 0.12 | 0.15 | 0.15 | 0.10 | 0.09 | 0.13 | 0.33 |
| Profit before tax | (1.26) | (1.17) | (0.15) | (0.41) | (0.29) | (1.96) | (0.85) | 8.98 |
| Tax | (0.18) | (0.20) | 0.03 | (0.10) | (0.03) | (0.57) | (0.08) | 0.95 |
Financial Statements
Figures in ₹ Cr; negatives in brackets. Updated 27 Oct 2026
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 42.77 | 35.75 | 35.67 | 34.17 | 35.00 | 33.90 | 27.69 | 29.57 |
| Revenue growth (YoY) | +22.2% | +5.5% | +28.8% | +15.6% | +18.3% | - | - | - |
| Other income | 0.61 | 0.76 | 0.33 | 0.36 | 0.27 | 0.12 | 0.87 | 10.63 |
| EBITDA | 6.96 | 5.27 | 4.17 | 2.28 | 3.01 | 3.06 | 1.31 | 2.19 |
| EBITDA margin | +16.3% | +14.7% | +11.7% | +6.7% | +8.6% | +9.0% | +4.7% | +7.4% |
| Depreciation | 1.13 | 1.13 | 1.14 | 1.13 | 1.12 | 0.90 | 1.31 | 1.29 |
| Interest | 0.15 | 0.17 | 0.20 | 0.22 | 0.18 | 0.18 | 0.19 | 0.43 |
| Profit before tax | 6.29 | 4.73 | 3.16 | 1.29 | 1.98 | 2.10 | 0.68 | 11.10 |
| Tax | 1.70 | 1.18 | 0.88 | 0.55 | 0.69 | 0.52 | 0.41 | 1.33 |
| Net profit | 4.59 | 3.55 | 2.28 | 0.74 | 1.29 | 1.58 | 0.27 | 9.77 |
| EPS (₹) | 2.55 | 1.85 | 1.59 | (0.20) | 0.74 | (0.08) | (0.50) | 14.94 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Revenue | 141 | 121 | 104 | 101 | 127 | 68.64 |
| Revenue growth | +16.4% | +15.7% | +3.1% | -20.4% | +85.3% | - |
| Other income | 1.71 | 11.89 | 1.53 | 2.28 | 2.64 | 0.96 |
| Total expenses | 126 | 113 | 103 | 97.95 | 108 | 60.52 |
| Employee cost | 15.59 | 14.05 | 13.94 | 11.73 | 12.51 | 8.71 |
| EBITDA | 14.82 | 7.60 | 1.12 | 3.33 | 18.82 | 8.12 |
| EBITDA margin | +10.5% | +6.3% | +1.1% | +3.3% | +14.8% | +11.8% |
| Depreciation | 4.53 | 4.79 | 4.54 | 4.24 | 4.02 | 4.61 |
| Interest | 0.85 | 1.29 | 2.02 | 2.20 | 1.74 | 1.76 |
| Profit before tax | 11.15 | 13.41 | (3.91) | (0.83) | 15.70 | 2.71 |
| Tax | 3.29 | 2.51 | 0.89 | 1.35 | 3.97 | 1.36 |
| Net profit | 2.09 | (3.67) | (6.29) | (4.76) | 4.97 | (0.42) |
| Net profit margin | +1.5% | -3.0% | -6.0% | -4.7% | +3.9% | -0.6% |
| EPS (₹) | 3.98 | 12.70 | (10.62) | (8.05) | 10.12 | (0.67) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Equity & liabilities | ||||||
| Share capital | 5.90 | 5.90 | 5.90 | 5.90 | 4.92 | 4.92 |
| Reserves & surplus | 67.02 | 64.61 | 57.15 | 63.30 | 54.66 | 49.21 |
| Shareholders' funds (net worth) | 72.92 | 70.51 | 63.05 | 69.20 | 59.58 | 54.13 |
| Minority interest | 49.55 | 44.69 | 41.29 | 40.47 | 38.51 | 32.44 |
| Secured loans | 1.03 | 2.06 | 9.08 | 6.91 | 5.53 | 7.98 |
| Unsecured loans | 7.71 | 5.72 | 13.05 | 9.80 | 17.47 | 12.53 |
| Total debt | 8.74 | 7.78 | 22.13 | 16.71 | 23.00 | 20.51 |
| Total liabilities | 132 | 123 | 128 | 128 | 122 | 107 |
| Assets | ||||||
| Gross block | 120 | 119 | 136 | 130 | 110 | 81.94 |
| Net block | 70.54 | 74.16 | 86.56 | 84.53 | 68.30 | 71.39 |
| Capital work in progress | 3.73 | 0.59 | 0.32 | 0.49 | 9.38 | 0.16 |
| Investments | 11.73 | 0.14 | 2.93 | 0.08 | 0.22 | 1.97 |
| Inventories | 44.94 | 34.04 | 33.80 | 31.32 | 23.84 | 27.47 |
| Sundry debtors | 19.86 | 28.04 | 19.89 | 19.87 | 13.55 | 16.61 |
| Cash & bank balances | 0.63 | 0.65 | 2.23 | 4.37 | 8.67 | 6.22 |
| Loans & advances | 9.95 | 5.55 | 11.06 | 7.70 | 16.84 | 10.00 |
| Total current assets | 75.38 | 68.28 | 66.98 | 63.26 | 62.90 | 60.30 |
| Total current liabilities | 27.33 | 16.84 | 25.72 | 16.95 | 14.63 | 20.35 |
| Net working capital | 48.05 | 51.44 | 41.26 | 46.31 | 48.27 | 39.95 |
| Total assets | 132 | 123 | 128 | 128 | 122 | 107 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Opening cash | 0.24 | 0.41 | 0.72 | 2.31 | 5.27 | 0.00 |
| Net cash from operating activities | 14.29 | (4.08) | 0.84 | (8.62) | 18.50 | 0.00 |
| Net cash from investing activities | (14.69) | 19.75 | (6.89) | 1.25 | (21.79) | 0.00 |
| Net cash from financing activities | 0.35 | (15.84) | 5.74 | 5.78 | 0.33 | 0.00 |
| Net change in cash | (0.05) | (0.17) | (0.31) | (1.59) | (2.96) | 0.00 |
| Closing cash | 0.63 | 0.65 | 2.23 | 4.37 | 8.67 | 6.22 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Growth | ||||||
| Sales growth | +16.4% | +15.7% | +3.1% | -20.4% | +85.3% | - |
| EBITDA growth | +95.0% | +578.6% | -66.4% | -82.3% | +131.8% | - |
| PBT growth | -16.9% | +9998.0% | -371.1% | - | +479.3% | +9997.0% |
| Net income growth | +157.0% | +41.7% | -32.1% | -195.8% | +1283.3% | - |
| Revenue CAGR (3Y) | +11.6% | -1.7% | +15.0% | - | - | - |
| EBITDA CAGR (3Y) | +64.5% | -26.1% | -48.3% | - | - | - |
| Profitability & leverage | ||||||
| Net income margin | +5.6% | +9.0% | -4.6% | -2.2% | +9.2% | +2.0% |
| Return on capital employed | +14.9% | +6.4% | -2.2% | +1.6% | +22.1% | +6.0% |
| Return on net worth | +11.0% | -0.4% | -7.3% | -3.4% | +20.6% | +2.5% |
| Debt / equity | 0.12 | 0.22 | 0.29 | 0.31 | 0.38 | 0.38 |
| Long-term debt / equity | 0.04 | 0.11 | 0.13 | 0.08 | 0.11 | 0.14 |
| Interest cover | 8.26 | 45.91 | -59.06 | -241.76 | 11.76 | 50.14 |
| Efficiency & per share | ||||||
| Fixed asset turnover | 1.17 | 0.95 | 0.79 | 0.84 | 1.33 | 0.84 |
| Inventory turnover | 3.56 | 3.56 | 3.21 | 3.67 | 4.96 | 2.50 |
| Debtors turnover | 5.87 | 5.04 | 5.25 | 6.06 | 8.44 | 4.13 |
| EPS (₹) | 3.98 | 12.70 | (10.62) | (8.05) | 10.12 | (0.67) |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 123.59 | 119.49 | 106.85 | 117.28 | 121.17 | 110.08 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 10.19 | 11.27 | 12.70 | 12.64 | 13.73 | 9.70 | 9.45 | 11.50 |
| Revenue growth (YoY) | -25.8% | +16.2% | +34.4% | +9.9% | +11.7% | - | - | - |
| Other income | 0.07 | 0.02 | 0.00 | 0.53 | 0.04 | 0.03 | 0.57 | 10.19 |
| Total expenses | 10.69 | 11.65 | 11.99 | 12.72 | 13.26 | 10.91 | 10.01 | 11.67 |
| EBITDA | (0.50) | (0.38) | 0.71 | (0.08) | 0.47 | (1.21) | (0.56) | (0.17) |
| EBITDA margin | -4.9% | -3.4% | +5.6% | -0.6% | +3.4% | -12.5% | -5.9% | -1.5% |
| Depreciation | 0.69 | 0.69 | 0.71 | 0.71 | 0.70 | 0.69 | 0.73 | 0.71 |
| Interest | 0.14 | 0.12 | 0.15 | 0.15 | 0.10 | 0.09 | 0.13 | 0.33 |
| Profit before tax | (1.26) | (1.17) | (0.15) | (0.41) | (0.29) | (1.96) | (0.85) | 8.98 |
| Tax | (0.18) | (0.20) | 0.03 | (0.10) | (0.03) | (0.57) | (0.08) | 0.95 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 50.35 | 42.94 | 49.09 | 42.55 | 52.38 | 44.41 | 51.31 |
| Revenue growth | +17.3% | -12.5% | +15.4% | -18.8% | +18.0% | -13.5% | - |
| Other income | 0.59 | 10.92 | 1.15 | 1.14 | 0.85 | 0.41 | 0.23 |
| Total expenses | 49.62 | 45.15 | 52.85 | 46.67 | 49.31 | 41.10 | 48.58 |
| Employee cost | 9.69 | 9.05 | 9.17 | 7.45 | 8.16 | 7.63 | 7.84 |
| EBITDA | 0.73 | (2.21) | (3.76) | (4.12) | 3.07 | 3.31 | 2.73 |
| EBITDA margin | +1.5% | -5.2% | -7.7% | -9.7% | +5.9% | +7.5% | +5.3% |
| Depreciation | 2.80 | 2.85 | 2.71 | 2.40 | 1.91 | 4.20 | 1.99 |
| Interest | 0.53 | 0.94 | 1.63 | 1.38 | 1.68 | 1.60 | 0.70 |
| Profit before tax | (2.01) | 4.92 | (6.95) | (6.76) | 0.33 | (2.08) | 0.27 |
| Tax | (0.29) | 0.29 | 0.00 | (0.41) | 0.14 | (0.46) | 0.37 |
| Net profit | (1.73) | (5.76) | (6.97) | (6.36) | 0.23 | (1.79) | (0.10) |
| Net profit margin | -3.4% | -13.4% | -14.2% | -15.0% | +0.4% | -4.0% | -0.2% |
| EPS (₹) | (2.91) | 7.87 | (11.78) | (10.78) | 0.35 | (3.29) | (0.25) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 5.90 | 5.90 | 5.90 | 5.90 | 4.92 | 4.92 | 4.92 |
| Reserves & surplus | 48.53 | 50.18 | 45.55 | 52.38 | 45.38 | 44.70 | 39.70 |
| Shareholders' funds (net worth) | 54.43 | 56.08 | 51.45 | 58.28 | 50.30 | 49.62 | 44.62 |
| Secured loans | 2.70 | 0.30 | 7.58 | 9.24 | 8.30 | 11.20 | 10.69 |
| Unsecured loans | 1.18 | 1.46 | 7.79 | 1.96 | 11.10 | 4.79 | 2.36 |
| Total debt | 3.88 | 1.76 | 15.37 | 11.20 | 19.40 | 15.99 | 13.05 |
| Total liabilities | 58.58 | 58.00 | 67.99 | 70.69 | 69.90 | 65.83 | 57.85 |
| Assets | |||||||
| Gross block | 45.93 | 45.62 | 56.08 | 54.10 | 41.74 | 40.73 | 38.83 |
| Net block | 26.91 | 29.38 | 39.88 | 40.45 | 29.93 | 30.59 | 32.88 |
| Capital work in progress | 0.06 | 0.04 | 0.00 | 0.04 | 8.94 | 0.12 | 0.69 |
| Investments | 22.60 | 22.59 | 22.56 | 22.52 | 22.55 | 23.66 | 15.04 |
| Inventories | 10.64 | 7.81 | 10.98 | 8.20 | 12.19 | 10.89 | 10.69 |
| Sundry debtors | 5.97 | 5.67 | 6.57 | 7.53 | 5.35 | 7.19 | 7.55 |
| Cash & bank balances | 0.03 | 0.04 | 0.07 | 0.08 | 0.14 | 0.34 | 0.96 |
| Loans & advances | 3.40 | 2.54 | 3.23 | 3.36 | 3.67 | 4.78 | 4.56 |
| Total current assets | 20.04 | 16.06 | 20.85 | 19.17 | 21.35 | 23.20 | 23.76 |
| Total current liabilities | 14.75 | 12.90 | 17.96 | 13.91 | 14.95 | 12.81 | 14.34 |
| Net working capital | 5.29 | 3.16 | 2.89 | 5.26 | 6.40 | 10.39 | 9.42 |
| Total assets | 58.58 | 58.00 | 67.99 | 70.69 | 69.90 | 65.83 | 57.85 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.02 | 0.03 | 0.01 | 0.05 | 0.26 | 0.87 | 2.16 |
| Net cash from operating activities | (2.02) | (1.59) | (3.06) | (1.42) | 6.80 | 0.67 | 4.23 |
| Net cash from investing activities | 0.28 | 16.14 | (2.04) | (3.55) | (8.78) | (2.65) | (8.43) |
| Net cash from financing activities | 1.75 | (14.56) | 5.12 | 4.94 | 1.77 | 1.37 | 2.91 |
| Net change in cash | 0.00 | (0.01) | 0.02 | (0.04) | (0.21) | (0.61) | (1.29) |
| Closing cash | 0.03 | 0.04 | 0.07 | 0.08 | 0.14 | 0.34 | 0.96 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +17.3% | -12.5% | +15.4% | -18.8% | +18.0% | -13.5% | - |
| EBITDA growth | +133.0% | +41.2% | +8.7% | -234.2% | -7.3% | +21.3% | - |
| PBT growth | - | +9998.0% | -2.8% | - | +9998.0% | - | -91.1% |
| Net income growth | +70.0% | +17.4% | -9.6% | -2865.2% | +112.9% | -1690.0% | - |
| Revenue CAGR (3Y) | +5.8% | -6.4% | +3.4% | -6.1% | +4.0% | -7.4% | -4.1% |
| EBITDA CAGR (3Y) | - | - | - | - | +11.4% | -9.1% | -19.4% |
| Profitability & leverage | |||||||
| Net income margin | -3.4% | +10.8% | -14.2% | -14.9% | +0.4% | -3.7% | -0.2% |
| Return on capital employed | -2.5% | -6.7% | -7.7% | -7.7% | +3.0% | -0.8% | +1.8% |
| Return on net worth | -3.1% | -10.7% | -12.7% | -11.7% | +0.4% | -3.4% | -0.3% |
| Debt / equity | 0.05 | 0.16 | 0.24 | 0.28 | 0.35 | 0.31 | 0.23 |
| Long-term debt / equity | 0.02 | 0.08 | 0.11 | 0.08 | 0.12 | 0.17 | 0.16 |
| Interest cover | -25.60 | -18.58 | -25.19 | -21.17 | 144.83 | -179.78 | 94.59 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 1.10 | 0.84 | 0.89 | 0.89 | 1.27 | 1.12 | 1.69 |
| Inventory turnover | 5.46 | 4.57 | 5.12 | 4.17 | 4.54 | 4.12 | 4.60 |
| Debtors turnover | 8.65 | 7.02 | 6.96 | 6.61 | 8.35 | 6.03 | 8.18 |
| EPS (₹) | (2.91) | 7.87 | (11.78) | (10.78) | 0.35 | (3.29) | (0.25) |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 92.25 | 95.04 | 87.19 | 98.78 | 102.30 | 100.92 | 90.74 |
To see the full year-wise statements and ratios of Makers Laboratories Ltd, buy the company report.
Board of directors of Makers Laboratories Ltd
Makers Laboratories has 6 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raj Kamal Prasad Verma Also directs: Resonance Specialties Limited, Evse Ready India Private Limited, Numantra Technologies Private Limited and 2 more | Director | 13 Feb 2019 | 7 Years 8 Months | Current |
| Prashant Godha | Director | 04 Nov 2020 | 5 Years 11 Months | Current |
| Vishal Babulal Jain Also directs: V Everywhere Foods LLP, Vipra Closures Private Limited | Director | 04 Nov 2020 | 5 Years 11 Months | Current |
| Saahil Umesh Parikh | Whole-Time Director | 02 Aug 2012 | 14 Years 2 Months | Current |
| Dipti Chinubhai Shah Also directs: Krebs Biochemicals and Industries Limited | Director | 29 Jan 2018 | 8 Years 8 Months | Current |
| Nilesh Jain Also directs: Resonance Specialties Limited | Whole-Time Director | 13 Feb 2019 | 7 Years 8 Months | Current |
Peer comparison
Makers Laboratories Ltd is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Makers Laboratories Ltdthis company | ₹140.59 Cr (FY 2026) | ₹2.09 Cr | 1.5% | 16.4% | 139 | Mumbai, Maharashtra, India |
| Surabhi Industries (India) Private Limited | ₹133.75 Cr (FY 2024) | -37.0% | Hyderabad, Telangana, India | |||
| Vikram Thermo (India) Limited | ₹133.72 Cr (FY 2025) | 5.0% | Ahmedabad, Gujarat, India | |||
| Strassenburg Pharmaceuticals Private Ltd. | ₹133.69 Cr (FY 2025) | 13.0% | Kolkata, West Bengal, India | |||
| Hemmo Pharmaceuticals Private Limited | ₹133.32 Cr (FY 2021) | 45.0% | Mumbai, Maharashtra, India | |||
| Ordain Health Care Global Private Limited | ₹133.17 Cr (FY 2025) | -4.0% | Maduranthakam, Tamil Nadu, India | |||
| Saimirra Innopharm Private Limited | ₹132.6 Cr (FY 2025) | 65.0% | Chennai, Tamil Nadu, India | |||
| Bengal Chemicals and Pharmaceuticals Ltd | ₹132.57 Cr (FY 2024) | 18.0% | Kolkata, West Bengal, India | |||
| Prosperity Drugs Private Limited | ₹131.43 Cr (FY 2025) | -1.0% | Solan, Himachal Pradesh, India | |||
| Dey's Medical Stores (Manufacturing) Ltd | ₹130.35 Cr (FY 2025) | -2.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Makers Laboratories Ltd, buy the company report.
Auditor
Makers Laboratories Ltd is audited by Natvarlal Vepari & Co. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Natvarlal Vepari & Co. | FY 2024 | 106971W |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 61.30%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.40% and retail and other public shareholders hold 38.30%.
Sep 2026
QUARTER
61.30% Promoters
0.40% DII (Domestic Institutional)
38.30% Retail & Others
Promoter holding - history
Now 61.30% · Sep 2026High 61.30% · Dec 2025Low 61.30% · Dec 2025
Shareholding trend - last 6 quarters
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 61.30% | 61.30% | 61.30% | 61.30% |
| Public | 38.70% | 38.70% | 38.70% | 38.70% |
Charges & borrowings
Open charges
₹21.32 Cr
Satisfied charges
₹30.67 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Nov 2020 | 100399703 | Yes Bank Limited | ₹8 Cr | Open | |
| 19 Oct 2000 | 90237394 | The Saraswat Co-Op Bank Ltd. | ₹3.9 Lakh | Open | |
| 19 Nov 1999 | 90237336 | Sarawat Co-Operative Bank Ltd. | ₹12.88 Lakh | Open | |
| 11 Mar 1998 | 90235833 | The Shamrao Vithal Co-Op. Bank Ltd. | ₹97 Lakh | Open | |
| 24 May 1996 | 90235732 | State Bank of India | ₹2.93 Cr | Open |
To see the full charge records of Makers Laboratories Ltd, buy the company report.
Total charge records: 20 View all charges
Deals & funding
Makers Laboratories Ltd has 33 deals on record (32 market trades, 1 rights issue); the latest was in May 2026.
Total deals
33
Market trades
32
Rights issue
1
Deals on record (5 of 33)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2020 | Market trade | ₹1.28 Cr | Buyer: Aamara Capital Private Limited Seller: an individual |
| Nov 2014 | Market trade | ₹27.2 Lakh | Buyer: Rapport Investment and Trading Co Pvt Ltd Seller: 2 individuals |
| Aug 2014 | Market trade | ₹19.2 Lakh | Buyer: Prakash Shah Huf Seller: Stephanotis Finance Limited |
| Jun 2010 | Market trade | ₹23 Lakh | Buyer: an individual Seller: Ginni Finance Pvt. Ltd. |
| May 2010 | Market trade | ₹26.5 Lakh | Buyer: Ginni Finance Pvt. Ltd. |
To see the full deal history of Makers Laboratories Ltd, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Makers Laboratories Ltd has 51 court cases on record: 42 filed by Makers Laboratories, 9 filed against it. 18 cases are pending and 33 are disposed.
Total cases
51
Filed by the company
42
Filed against the company
9
Pending
18
Disposed
33
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 39 | 2 | 17 |
| High courts | 12 | 7 | 1 |
Cases on record (5 of 51)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Ipca Laboratories Limited and Anr | Disposed |
| Bombay High Court | Appeal | Filed by the company against Ankur Drugs and Pharma Limited.Through Official Liquidator | Disposed |
| Bombay High Court | Court case (S) | Filed against the company by Ipca Laboratories Limited and Anr | Disposed |
| High Court of Delhi | Court case (CS(OS)) | Filed against the company by Win-Medicare P.Ltd. | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SS CASES S) | Filed by the company against M - S Sanjana Healthcare Pvt.Ltd. | Disposed |
To see the full case history of Makers Laboratories Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Makers Laboratories Ltd was last rated by Care on 24 Mar 2022.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 24 Mar 2022 |
To see the full credit ratings and regulatory alerts of Makers Laboratories Ltd, buy the company report.
MSME payment delays
Makers Laboratories Ltd has 15 MSME Form 1 returns on record between 2019 and 2024, listing 512 overdue payments to 70 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 70)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| Yaari Healthcare LLP | |||
| Shantilal and Co | |||
| an individual supplier |
To see the full MSME payment records of Makers Laboratories Ltd, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Makers Laboratories has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Resonance Specialties Limited | L25209MH1989PLC051993 |
To see the full group structure of Makers Laboratories Ltd, buy the company report.
Employees & EPFO
Makers Laboratories Ltd has a workforce of 139 employees on its EPFO records as of Feb 27, 2025, across 2 active EPFO establishments.
Employee count
139
Active EPFO establishments
2
Employee growth
-4.79%
GST
Makers Laboratories has 14 GST registrations: 4 active and 10 cancelled or inactive.
Total GSTINs
14
Active
4
Cancelled / inactive
10
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACM8382J2Z1 | Maharashtra | Active | 11 Jul 2017 |
| 03AAACM8382J1ZC | Punjab | Active | 01 Jul 2017 |
| 24AAACM8382J1Z8 | Gujarat | Active | 01 Jul 2017 |
| 06AAACM8382J1Z6 | Haryana | Active | 01 Oct 2018 |
To see the full GST registrations and return filing status of Makers Laboratories Ltd, buy the company report.
Recent activity
Makers Laboratories Ltd has 16 board changes on record since 1988: 11 appointments and 5 cessations. The latest: Prashant Godha was appointed as Director on 04 Nov 2020.
Filing
Makers Laboratories Ltd has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai I.
Charges
A charge registered on 10 Jul 2019 via Charge ID 100279254 with Yes Bank Limited was fully satisfied on 27 Oct 2025.
Charges
A charge with Yes Bank Limited of Rs. 8.00 Cr registered on 04 Nov 2020 with Charge ID 100399703 was modified on 08 Oct 2025.
AGM
Makers Laboratories Ltd last Annual general meeting of members was held on 08 Aug 2025 as per latest MCA records.
Charges
A charge registered on 25 Sep 2018 via Charge ID 100210705 with Yes Bank Limited was fully satisfied on 01 Jan 2024.
Charges
A charge with Yes Bank Limited of Rs. 10.70 Cr registered on 10 Jul 2019 with Charge ID 100279254 was modified on 01 Dec 2021.
Charges
A charge with Yes Bank Limited amounted to Rs. 8.00 Cr with Charge ID 100399703 was registered on 04 Nov 2020.
Appointed
Prashant Godha was appointed as Director.
Appointed
Vishal Babulal Jain was appointed as Director.
Ceased
Popatlal Mukanchand Kathariya ceased to be Director.
Charges
A charge with Yes Bank Limited amounted to Rs. 10.70 Cr with Charge ID 100279254 was registered on 10 Jul 2019.
Ceased
Kailashchandra Jain ceased to be Director.
47 earlier events are in the company report.
News
Frequently asked questions
Makers Laboratories is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 July 1984 (42+ years old) and is registered under CIN L24230MH1984PLC033389. Listed on BSE: 506919 and NSE: MAKERSL.
Makers Laboratories reported revenue of ₹140.59 Cr for FY 2025-26 (up 16.4% YoY) based on consolidated financials.
Makers Laboratories has 6 current directors:
- Saahil Umesh Parikh - Whole-Time Director
- Nilesh Jain - Whole-Time Director
- Raj Kamal Prasad Verma - Director
- Prashant Godha - Director
- Vishal Babulal Jain - Director
- Dipti Chinubhai Shah - Director
The latest financial statements of Makers Laboratories on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 08 August 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Makers Laboratories is 27AAACM8382J2Z1, registered in Maharashtra. The company has 14 GST registrations in all, of which 4 are active and 10 are cancelled or inactive. Other active GSTINs include 03AAACM8382J1ZC (Punjab), 24AAACM8382J1Z8 (Gujarat), 06AAACM8382J1Z6 (Haryana).
The CIN (Corporate Identification Number) of Makers Laboratories is L24230MH1984PLC033389. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Makers Laboratories is a listed company as per MCA records. Its shares are listed on both BSE (code: 506919) and NSE (symbol: MAKERSL).
Makers Laboratories has 51 court cases on record: 42 filed by the company and 9 filed against it. 18 are pending. Most are in the district courts.
Makers Laboratories was incorporated on 09 July 1984, making it 42+ years old. It is registered with the Registrar of Companies, Mumbai.
Makers Laboratories has 33 deals on record (32 market trades, 1 rights issue); the latest was in May 2026.
The peers of Makers Laboratories by revenue are Surabhi Industries (India) Private Limited, Vikram Thermo (India) Limited, Strassenburg Pharmaceuticals Private Ltd, Hemmo Pharmaceuticals Private Limited, Ordain Health Care Global Private Limited and 4 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Prashant Godha was appointed as Director on 04 Nov 2020. Vishal Babulal Jain was appointed as Director on 04 Nov 2020. Popatlal Mukanchand Kathariya ceased to be Director on 24 Sep 2020. Makers Laboratories has 16 board changes on record in total.